Financial Analysis: Adaptive Biotechnologies Corp (ADPT)’s Ratios Unveil Key Insights

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Adaptive Biotechnologies Corp’s stock clocked out at $5.58, up 6.08% from its previous closing price of $5.26. In other words, the price has increased by $6.08 from its previous closing price. On the day, 0.84 million shares were traded. ADPT stock price reached its highest trading level at $5.59 during the session, while it also had its lowest trading level at $5.09.

Ratios:

To gain a deeper understanding of ADPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.84 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.94 whereas as Long-Term Debt/Eq ratio is at 0.90.

On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.

Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Taylor Stacy L sold 26,922 shares for $4.50 per share. The transaction valued at 121,079 led to the insider holds 139,365 shares of the business.

STACY L TAYLOR bought 26,922 shares of ADPT for $121,079 on Aug 22 ’24. On Mar 05 ’24, another insider, PISKEL KYLE, who serves as the Principal Accounting Officer of the company, sold 7,727 shares for $3.43 each. As a result, the insider received 26,504 and left with 123,318 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 822893760 and an Enterprise Value of 757099904. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.88 while its Price-to-Book (P/B) ratio in mrq is 3.41. Its current Enterprise Value per Revenue stands at 4.486 whereas that against EBITDA is -4.614.

Stock Price History:

Over the past 52 weeks, ADPT has reached a high of $5.80, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 17.64%, while the 200-Day Moving Average is calculated to be 42.86%.

Shares Statistics:

It appears that ADPT traded 1.07M shares on average per day over the past three months and 859850 shares per day over the past ten days. A total of 145.08M shares are outstanding, with a floating share count of 142.33M. Insiders hold about 3.49% of the company’s shares, while institutions hold 97.12% stake in the company. Shares short for ADPT as of 1728950400 were 9476574 with a Short Ratio of 8.89, compared to 1726185600 on 9630469. Therefore, it implies a Short% of Shares Outstanding of 9476574 and a Short% of Float of 8.25.

Most Popular